Global Leber's Hereditary Optic Neuropathy Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Leber's Hereditary Optic Neuropathy Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Leber's Hereditary Optic Neuropathy Drug by Country/Region, 2017, 2022 & 2028

2.2 Leber's Hereditary Optic Neuropathy Drug Segment by Type

2.2.1 Elamipretide

2.2.2 GS-011

2.2.3 IXC-201

2.2.4 KH-176

2.2.5 Others

2.3 Leber's Hereditary Optic Neuropathy Drug Sales by Type

2.3.1 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Type (2017-2022)

2.4 Leber's Hereditary Optic Neuropathy Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Leber's Hereditary Optic Neuropathy Drug Sales by Application

2.5.1 Global Leber's Hereditary Optic Neuropathy Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Application (2017-2022)

3 Global Leber's Hereditary Optic Neuropathy Drug by Company

3.1 Global Leber's Hereditary Optic Neuropathy Drug Breakdown Data by Company

3.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Company (2020-2022)

3.1.2 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Company (2020-2022)

3.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Company (2020-2022)

3.2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company (2020-2022)

3.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Company

3.4 Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Product Location Distribution

3.4.2 Players Leber's Hereditary Optic Neuropathy Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Leber's Hereditary Optic Neuropathy Drug by Geographic Region

4.1 World Historic Leber's Hereditary Optic Neuropathy Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Geographic Region

4.2 World Historic Leber's Hereditary Optic Neuropathy Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Country/Region

4.3 Americas Leber's Hereditary Optic Neuropathy Drug Sales Growth

4.4 APAC Leber's Hereditary Optic Neuropathy Drug Sales Growth

4.5 Europe Leber's Hereditary Optic Neuropathy Drug Sales Growth

4.6 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Growth

5 Americas

5.1 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country

5.1.1 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022)

5.1.2 Americas Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022)

5.2 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Type

5.3 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region

6.1.1 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region (2017-2022)

6.1.2 APAC Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2017-2022)

6.2 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Type

6.3 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Leber's Hereditary Optic Neuropathy Drug by Country

7.1.1 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022)

7.1.2 Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022)

7.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type

7.3 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug by Country

8.1.1 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type

8.3 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug

10.3 Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug

10.4 Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Leber's Hereditary Optic Neuropathy Drug Distributors

11.3 Leber's Hereditary Optic Neuropathy Drug Customer

12 World Forecast Review for Leber's Hereditary Optic Neuropathy Drug by Geographic Region

12.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size Forecast by Region

12.1.1 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Region (2023-2028)

12.1.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Type

12.7 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Application

13 Key Players Analysis

13.1 Alkeus Pharmaceuticals, Inc.

13.1.1 Alkeus Pharmaceuticals, Inc. Company Information

13.1.2 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

13.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Alkeus Pharmaceuticals, Inc. Main Business Overview

13.1.5 Alkeus Pharmaceuticals, Inc. Latest Developments

13.2 Biovista Inc.

13.2.1 Biovista Inc. Company Information

13.2.2 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

13.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biovista Inc. Main Business Overview

13.2.5 Biovista Inc. Latest Developments

13.3 GenSight Biologics S.A.

13.3.1 GenSight Biologics S.A. Company Information

13.3.2 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Offered

13.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GenSight Biologics S.A. Main Business Overview

13.3.5 GenSight Biologics S.A. Latest Developments

13.4 Ixchel Pharma, LLC

13.4.1 Ixchel Pharma, LLC Company Information

13.4.2 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Offered

13.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ixchel Pharma, LLC Main Business Overview

13.4.5 Ixchel Pharma, LLC Latest Developments

13.5 Khondrion BV

13.5.1 Khondrion BV Company Information

13.5.2 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Offered

13.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Khondrion BV Main Business Overview

13.5.5 Khondrion BV Latest Developments

13.6 Spark Therapeutics, Inc.

13.6.1 Spark Therapeutics, Inc. Company Information

13.6.2 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

13.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Spark Therapeutics, Inc. Main Business Overview

13.6.5 Spark Therapeutics, Inc. Latest Developments

13.7 Stealth BioTherapeutics Inc.

13.7.1 Stealth BioTherapeutics Inc. Company Information

13.7.2 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

13.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Stealth BioTherapeutics Inc. Main Business Overview

13.7.5 Stealth BioTherapeutics Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Leber's Hereditary Optic Neuropathy Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Leber's Hereditary Optic Neuropathy Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Elamipretide

Table 4. Major Players of GS-011

Table 5. Major Players of IXC-201

Table 6. Major Players of KH-176

Table 7. Major Players of Others

Table 8. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)

Table 10. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)

Table 15. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2017-2022)

Table 16. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Leber's Hereditary Optic Neuropathy Drug Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Company (2020-2022)

Table 20. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Producing Area Distribution and Sales Area

Table 24. Players Leber's Hereditary Optic Neuropathy Drug Products Offered

Table 25. Leber's Hereditary Optic Neuropathy Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Leber's Hereditary Optic Neuropathy Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Leber's Hereditary Optic Neuropathy Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Leber's Hereditary Optic Neuropathy Drug

Table 69. Key Market Challenges & Risks of Leber's Hereditary Optic Neuropathy Drug

Table 70. Key Industry Trends of Leber's Hereditary Optic Neuropathy Drug

Table 71. Leber's Hereditary Optic Neuropathy Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Leber's Hereditary Optic Neuropathy Drug Distributors List

Table 74. Leber's Hereditary Optic Neuropathy Drug Customer List

Table 75. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Forecast by Region

Table 77. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. Alkeus Pharmaceuticals, Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

Table 97. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Alkeus Pharmaceuticals, Inc. Main Business

Table 99. Alkeus Pharmaceuticals, Inc. Latest Developments

Table 100. Biovista Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

Table 102. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Biovista Inc. Main Business

Table 104. Biovista Inc. Latest Developments

Table 105. GenSight Biologics S.A. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Offered

Table 107. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. GenSight Biologics S.A. Main Business

Table 109. GenSight Biologics S.A. Latest Developments

Table 110. Ixchel Pharma, LLC Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Offered

Table 112. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Ixchel Pharma, LLC Main Business

Table 114. Ixchel Pharma, LLC Latest Developments

Table 115. Khondrion BV Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Offered

Table 117. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Khondrion BV Main Business

Table 119. Khondrion BV Latest Developments

Table 120. Spark Therapeutics, Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

Table 122. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Spark Therapeutics, Inc. Main Business

Table 124. Spark Therapeutics, Inc. Latest Developments

Table 125. Stealth BioTherapeutics Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered

Table 127. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Stealth BioTherapeutics Inc. Main Business

Table 129. Stealth BioTherapeutics Inc. Latest Developments

List of Figures

Figure 1. Picture of Leber's Hereditary Optic Neuropathy Drug

Figure 2. Leber's Hereditary Optic Neuropathy Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Leber's Hereditary Optic Neuropathy Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Elamipretide

Figure 10. Product Picture of GS-011

Figure 11. Product Picture of IXC-201

Figure 12. Product Picture of KH-176

Figure 13. Product Picture of Others

Figure 14. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type in 2021

Figure 15. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2017-2022)

Figure 16. Leber's Hereditary Optic Neuropathy Drug Consumed in Hospital

Figure 17. Global Leber's Hereditary Optic Neuropathy Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 18. Leber's Hereditary Optic Neuropathy Drug Consumed in Clinic

Figure 19. Global Leber's Hereditary Optic Neuropathy Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 20. Leber's Hereditary Optic Neuropathy Drug Consumed in Others

Figure 21. Global Leber's Hereditary Optic Neuropathy Drug Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application in 2021

Figure 24. Leber's Hereditary Optic Neuropathy Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company in 2021

Figure 26. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)

Figure 31. Americas Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)

Figure 33. APAC Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)

Figure 35. Europe Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2021

Figure 39. Americas Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2021

Figure 40. United States Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region in 2021

Figure 45. APAC Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Regions in 2021

Figure 46. China Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2021

Figure 53. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2021

Figure 54. Germany Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug in 2021

Figure 67. Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug

Figure 68. Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles